Jabil has acquired contract development and manufacturing organisation (CDMO) Pharmaceutics International (Pii) to offer ...

Jabil (JBL) reachead $163.62 at the closing of the latest trading day, reflecting a +1.11% change compared to its last close.

Jabil's diversification in end markets, particularly Auto & Transportation and Healthcare & Packaging, is driving revenue ...

For superior performance in quality, delivery, innovation and partnership related to fluid dispensing systems used in ...

With one foot already in the healthcare realm, multi-industry manufacturer Jabil is beefing up its biopharma bona fides with ...

(NYSE:JBL) share price has soared 322% over five years. If that doesn't get you thinking about long term investing, we don't know what will. Also pleasing for shareholders was the 26% gain in the last ...

Chicago Partners Investment Group LLC purchased a new stake in Jabil Inc. (NYSE:JBL – Free Report) during the 4th quarter, ...

Jabil Inc., a provider of engineering, manufacturing, and supply chain solutions, has acquired Pharmaceutics International ...

Learn more about whether Jabil Inc. or TD SYNNEX Corporation is a better investment based on AAII's A+ Investor grades, which ...

In a regulatory filing, Jabil (JBL) director Christopher Holland disclosed the sale of 3,400 common shares of the company on January 31 at a ...

A consortium of investors led by Signet Healthcare Partners, Athyrium Capital Management, Hildred Capital and Pharmascience Inc. today announced they have exited their equity stake in Pharmaceutics ...

Jabil, Inc. JBL recently announced that it has completed the acquisition of Pharmaceutics International, Inc. for an ...